HAE vs. ON

Last updated Apr 1, 2026

Compare and contrast key facts about Haemonetics Corporation (HAE) and ON Semiconductor Corporation (ON).

Performance

HAE vs. ON - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Haemonetics Corporation (HAE) and ON Semiconductor Corporation (ON). The values are adjusted to include any dividend payments, if applicable.

HAE vs. ON - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HAE Haemonetics Corporation	-29.68%	2.65%	-8.69%	8.72%	48.28%	-55.33%	3.35%	14.84%	72.26%	44.48%
ON ON Semiconductor Corporation	14.35%	-14.12%	-24.52%	33.93%	-8.17%	107.52%	34.25%	47.67%	-21.16%	64.11%

Fundamentals

Market Cap HAE : $2.65B ON : $24.91B
EPS HAE : $3.68 ON : $0.29
PE Ratio HAE : 15.31 ON : 210.64
PS Ratio HAE : 2.04 ON : 4.25
PB Ratio HAE : 2.91 ON : 3.25
Total Revenue (TTM) HAE : $1.32B ON : $6.00B
Gross Profit (TTM) HAE : $782.04M ON : $1.98B
EBITDA (TTM) HAE : $347.39M ON : $639.00M

Returns By Period

In the year-to-date period, HAE achieves a -29.68% return, which is significantly lower than ON's 14.35% return. Over the past 10 years, HAE has underperformed ON with an annualized return of 4.79%, while ON has yielded a comparatively higher 20.37% annualized return.

HAE

• 1D: 2.60%
• 1M: -10.99%
• YTD: -29.68%
• 6M: 15.63%
• 1Y: -11.31%
• 3Y*: -12.02%
• 5Y*: -12.84%
• 10Y*: 4.79%

ON

• 1D: 11.25%
• 1M: -6.86%
• YTD: 14.35%
• 6M: 25.57%
• 1Y: 52.17%
• 3Y*: -9.06%
• 5Y*: 7.62%
• 10Y*: 20.37%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

HAE vs. ON — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HAE

HAE Risk / Return Rank: 32
HAE Sharpe Ratio Rank: 31
HAE Sortino Ratio Rank: 31
HAE Omega Ratio Rank: 31
HAE Calmar Ratio Rank: 33
HAE Martin Ratio Rank: 33

ON

ON Risk / Return Rank: 72
ON Sharpe Ratio Rank: 73
ON Sortino Ratio Rank: 70
ON Omega Ratio Rank: 69
ON Calmar Ratio Rank: 76
ON Martin Ratio Rank: 71

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HAE vs. ON - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Haemonetics Corporation (HAE) and ON Semiconductor Corporation (ON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HAE	ON	Difference
Sharpe ratio Return per unit of total volatility	-0.22	0.89	-1.11
Sortino ratio Return per unit of downside risk	0.04	1.57	-1.53
Omega ratio Gain probability vs. loss probability	1.01	1.21	-0.20
Calmar ratio Return relative to maximum drawdown	-0.28	1.82	-2.10
Martin ratio Return relative to average drawdown	-0.49	3.61	-4.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HAE vs. ON - Sharpe Ratio Comparison

The current HAE Sharpe Ratio is -0.22, which is lower than the ON Sharpe Ratio of 0.89. The chart below compares the historical Sharpe Ratios of HAE and ON, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	HAE	ON	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.22	0.89	-1.11
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.30	0.15	-0.45
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.12	0.41	-0.29
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	0.06	+0.13

Correlation

The correlation between HAE and ON is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

HAE vs. ON - Dividend Comparison

Neither HAE nor ON has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

HAE vs. ON - Drawdown Comparison

The maximum HAE drawdown since its inception was -68.62%, smaller than the maximum ON drawdown of -96.22%. Use the drawdown chart below to compare losses from any high point for HAE and ON.

Drawdown Indicators

	HAE	ON	Difference
Max Drawdown Largest peak-to-trough decline	-68.62%	-96.22%	+27.60%
Max Drawdown (1Y) Largest decline over 1 year	-39.02%	-28.10%	-10.92%
Max Drawdown (5Y) Largest decline over 5 years	-63.08%	-70.44%	+7.36%
Max Drawdown (10Y) Largest decline over 10 years	-68.62%	-70.44%	+1.82%
Current Drawdown Current decline from peak	-59.59%	-42.71%	-16.88%
Average Drawdown Average peak-to-trough decline	-23.68%	-53.49%	+29.81%
Ulcer Index Depth and duration of drawdowns from previous peaks	21.93%	14.20%	+7.73%

Volatility

HAE vs. ON - Volatility Comparison

The current volatility for Haemonetics Corporation (HAE) is 7.64%, while ON Semiconductor Corporation (ON) has a volatility of 17.74%. This indicates that HAE experiences smaller price fluctuations and is considered to be less risky than ON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HAE	ON	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.64%	17.74%	-10.10%
Volatility (6M) Calculated over the trailing 6-month period	35.47%	35.17%	+0.30%
Volatility (1Y) Calculated over the trailing 1-year period	52.08%	58.93%	-6.85%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.28%	51.92%	-8.64%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	39.85%	50.28%	-10.43%

Financials

HAE vs. ON - Profitability Comparison

The chart below illustrates the profitability comparison between Haemonetics Corporation and ON Semiconductor Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

HAE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Haemonetics Corporation reported a gross profit of 202.39M and revenue of 338.97M. Therefore, the gross margin over that period was 59.7%.

ON - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, ON Semiconductor Corporation reported a gross profit of 551.00M and revenue of 1.53B. Therefore, the gross margin over that period was 36.0%.

HAE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Haemonetics Corporation reported an operating income of 67.40M and revenue of 338.97M, resulting in an operating margin of 19.9%.

ON - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, ON Semiconductor Corporation reported an operating income of 200.10M and revenue of 1.53B, resulting in an operating margin of 13.1%.

HAE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Haemonetics Corporation reported a net income of 44.74M and revenue of 338.97M, resulting in a net margin of 13.2%.

ON - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, ON Semiconductor Corporation reported a net income of 181.80M and revenue of 1.53B, resulting in a net margin of 11.9%.